Hematrak Abnormal Recognition
by Geometric Data, Div. Smithkline Corp.
510(k) K791041
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK791041 | Date4 Sep 1979 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- GKZ
- Device Class
- Class II
- Regulation
- 21 CFR Part 864.5220
- Advisory Committee
- Hematology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 24 Sep 2026
Hematrak Abnormal Recognition is a hematology device used for the recognition of abnormal cells. It is classified as a Counter, Differential Cell device and is designed for use in hematology laboratories.
The device is manufactured by Geometric Data, Div. Smithkline Corp. and received FDA 510(k) clearance with number K791041 on September 4, 1979. It is a Class II device with product code GKZ and is intended for laboratory use. The device is not specified as single-use or reusable, and no information regarding sterility, MRI safety, or storage conditions is provided.
Other devices from Geometric Data, Div. Smithkline Corp.
See all devices from Geometric Data, Div. Smithkline Corp. →
Questions
AI-generated answers, 24 Sep 2026
What is the HEMATRAK Abnormal Recognition device used for?
The HEMATRAK Abnormal Recognition is a hematology device designed for the recognition of abnormal cells in laboratory settings. It is classified as a Counter, Differential Cell device and is intended for use in hematology laboratories to assist in cell identification and analysis.
Is the HEMATRAK Abnormal Recognition device single-use or reusable?
The device information does not specify whether the HEMATRAK Abnormal Recognition is designed for single-use or multiple reuse. This detail is not provided in the available documentation, so users should consult the manufacturer's instructions for specific guidance on usage and disposal protocols.
What regulatory approvals does the HEMATRAK Abnormal Recognition have?
The HEMATRAK Abnormal Recognition received FDA 510(k) clearance with number K791041 on September 4, 1979. It is classified as a Class II device with product code GKZ and is intended for laboratory use. The device is manufactured by Geometric Data, Div. Smithkline Corp.
What are the specifications of the HEMATRAK Abnormal Recognition device?
The HEMATRAK Abnormal Recognition is a hematology device classified as a Counter, Differential Cell device. It has product code GKZ and is a Class II device. The device is designed for laboratory use and received FDA clearance through the traditional 510(k) pathway, with a decision description of 'Substantially Equivalent'.